Investor Presentaiton

FY 2020 SALES SUMMARY Consolidated Net Sales Net Sales ($ in millions) $83.7 Breast Products Segment Net Sales & Y/Y Growth Net Sales/ Growth ($ in millions) $55.0 $46.4 $71.2 $68.1 $17.9 $37.0 +40% +22% $12.8 $46.4 $10.4 +28% $37.0 $12.6 +47% $15.3 +21% $55.0 $8.6 +13% $11.2 +19% $9.3 -17% $9.4 +15% $37.3 $31.1 $16.2 2018 2019 2020 ■MiraDry Breast Products $8.5 +14% $9.8 $12.5 +28% +14% 2018 2019 2020 Q1 Q2 Q3 Q4 Shift in investment to Breast Products from miraDry in 2Q20 reflected in miraDry net sales decline FY2020 Momentum continued into 2021 Cash balance of $80.4M as of March 31, 2021 Including Net Proceeds of ~$39.2M from February 2021 Public Offering sientra. 15

View entire presentation